A Novel Palladium-Catalyzed Dicarbonylation Process Leading to Coumarins
摘要:
[GRAPHICS]A novel approach to coumarin derivatives has been developed starting from readily available 2-(1-hydroxyprop-2-ynyl)phenols, based on an unprecedented palladium-catalyzed dicarbonylation process. Reactions were carried out in the presence of catalytic amounts of PdI2 in conjunction with an excess of KI in MeOH as the solvent at room temperature and under 90 atm of CO to give 3-[(methoxycarbonyl)-methyl]coumarins in good to high isolated yields (62-87%).
GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES
申请人:BioMarin Pharmaceutical Inc.
公开号:EP3912977A1
公开(公告)日:2021-11-24
Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions associated with the enzyme glucosylceramide synthase (GCS).
本文描述了式 I 的化合物、制造此类化合物的方法、含有此类化合物的药物组合物和药物,以及使用此类化合物治疗或预防与葡萄糖酰胺合成酶 (GCS) 相关的疾病或病症的方法。
A Novel Palladium-Catalyzed Dicarbonylation Process Leading to Coumarins
[GRAPHICS]A novel approach to coumarin derivatives has been developed starting from readily available 2-(1-hydroxyprop-2-ynyl)phenols, based on an unprecedented palladium-catalyzed dicarbonylation process. Reactions were carried out in the presence of catalytic amounts of PdI2 in conjunction with an excess of KI in MeOH as the solvent at room temperature and under 90 atm of CO to give 3-[(methoxycarbonyl)-methyl]coumarins in good to high isolated yields (62-87%).